Literature DB >> 6502792

Dietary carcinogens and anti-carcinogens.

B N Ames.   

Abstract

The scientific understanding of cancer and degenerative disease is being aided by new methodologies which are now used to approach the problem of environmental and occupational carcinogens and anticarcinogens. This paper reviews these powerful new tools and relates them to "natural" mutagens and carcinogens in food. It also discusses the use of oxygen radicals as a cause of degenerative disease associated with aging. Since no human diet can be totally free of carcinogens or mutagens, it is necessary to consider the risks of alternative courses of actions and to quantitate the magnitude of the risks through the "quantification" of these risks. Since carcinogens and anticarcinogens differ in their potency in animals over one million fold, the extrapolation of risks from rodents to humans is difficult but it is a first step. Despite better understanding of all of these risks, it is important to realize that the overall trend in life expectancy in the United States is continuing steadily to improve.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6502792     DOI: 10.3109/15563658408992561

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  5 in total

1.  Design, synthesis and evaluation of new chromone-derived aminophosphonates as potential acetylcholinesterase inhibitor.

Authors:  Sarfaraz Shaikh; Pratik Dhavan; M M V Ramana; B L Jadhav
Journal:  Mol Divers       Date:  2020-03-02       Impact factor: 2.943

2.  Safety Profile Investigations of Meyna spinosa (Roxb.) and Oroxylum indicum (Linn.) Extracts Collected from Northeast India.

Authors:  Shweta Singh; Pronobesh Chattopadhyay; Sahindra Kumar Borthakur; Rudragoud Policegoudra
Journal:  Pharmacogn Mag       Date:  2018-01-31       Impact factor: 1.085

3.  Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway.

Authors:  Yizhou Yao; Xuchao Wang; Diyuan Zhou; Hao Li; Huan Qian; Jiawen Zhang; Linhua Jiang; Bin Wang; Qi Lin; Xinguo Zhu
Journal:  Aging (Albany NY)       Date:  2020-07-02       Impact factor: 5.682

4.  Low expression of Aldo-keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma.

Authors:  Yuanwei Guo; Weihao Luo; Zheng Hu; Jia Li; Xiaojie Li; Huiqiu Cao; Jun Li; Bo Wen; Jian Zhang; Hao Cheng; Wangyuan Guo; Tan Tan; Dixian Luo
Journal:  Cell Biosci       Date:  2016-03-05       Impact factor: 7.133

Review 5.  Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.

Authors:  Li Huang; Rongzhang He; Weihao Luo; Yuan-Shan Zhu; Jia Li; Tan Tan; Xi Zhang; Zheng Hu; Dixian Luo
Journal:  Recent Pat Anticancer Drug Discov       Date:  2016       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.